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polymorphismAbstract KCNQ1 has been identified as a susceptibility gene of type 2 diabetes mellitus (T2DM) in
Asian populations through genome-wide association studies. However, studies on the association
between gene polymorphism of KCNQ1 and T2DM complications remain unclear. To further ana-
lyze the association between different alleles at the single nucleotide polymorphism (SNP) rs2237892
within KCNQ1 and TD2M and its complications, we conducted a case-control study in a Chinese
Han population. The C allele of rs2237892 variant contributed to susceptibility to T2DM (odds
ratio [OR], 1.45; 95% confidence interval [CI], 1.20–1.75). Genotypes CT (OR, 1.97; 95% CI,
1.24–3.15) and CC (OR, 2.49; 95% CI, 1.57–3.95) were associated with an increased risk of
T2DM. Multivariate regression analysis was performed with adjustment of age, gender, and body
mass index. We found that systolic blood pressure (P= 0.015), prevalence of hypertension
(P= 0.037), and risk of macrovascular disease (OR, 2.10; CI, 1.00–4.45) were significantly higher
in subjects with the CC genotype than in the combined population with genotype either CT ornces and
Zhang W et al / KCNQ1 Variant in Chinese with Type 2 Diabetes 365TT. Therefore, our data support that KCNQ1 is associated with an increased risk for T2DM and
might contribute to the higher incidence of hypertension and macrovascular complications in
patients with T2DM carrying the risk allele C though it needs further to be confirmed in a larger
population.Introduction
Type 2 diabetes mellitus (T2DM) is becoming increasingly
prevalent throughout the world. The number of people living
with diabetes is expected to increase from 387 million in
2014 to 592 million by 2035 according to the 6th Edition of
the International Diabetes Federation’s (IDF) Diabetes Atlas
[1]. In China alone, there are more than 113.9 million adults
with diabetes and another 493.4 million with prediabetes up
to 2013 [2]. Although lifestyle changes, an increasing preva-
lence of obesity, and an increasingly aging population are
important drivers of this epidemic, genetic factors also play a
major role in T2DM susceptibility [3]. The extensive applica-
tion of genome-wide association studies (GWAS) in the iden-
tification of common genetic variants has greatly contributed
to the discovery of diabetes susceptibility genes. To date, at
least 40 genetic loci have been convincingly associated with
T2DM, including KCNQ1, CDKAL1, TCF7L2, HMG20A,
HNF4A, HNF1B, and DUSP9 [4–6].
The potassium channel, voltage gated KQT-like subfamily
Q, member 1 encoded by KCNQ1 is essential for the repolar-
ization phase of the cardiac action potential. KCNQ1 protein
can form heteromultimers with two other potassium channel
proteins, KCNE1 and KCNE3. It is well known that KCNQ1
gene mutations could result in hereditary long QT syndrome 1,
Jervell and Lange-Nielsen syndrome, and familial atrial fibril-
lation [7]. KCNQ1 is also expressed in insulin-producing cells.
Inhibition of KCNQ1 channel activity by the selective inhibi-
tor chromanol 293B significantly increases insulin secretion
in INS-1 cells [8], whereas KCNQ1 overexpression in MIN6
cells results in markedly impaired insulin secretion by glucose,
pyruvate, or tolbutamide [9].
Multiple genetic variants have been identified in KCNQ1,
including three main single nucleotide polymorphisms (SNPs)
located in the intron 15 of KCNQ1, i.e., rs2237892, rs2237895,
and rs2237897. Several GWAS analyses showed that these
variants are associated with T2DM and impaired insulin secre-
tion in different populations including Asians, Europeans, and
American Indians [10–12]. In addition, the SNPs of KCNQ1
such as rs2074196, rs2237892, and rs2237895, were demon-
strated to be associated with the risk of gestational diabetes
mellitus in Koreans [13], and rs2283228 might contribute to
the susceptibility of East Asians (Japanese and Singaporeans)
to diabetic nephropathy [14]. These findings indicate that
KCNQ1 variants are clearly associated with a range of patho-
logical conditions. However, whether KCNQ1 variants are
associated with the diseases other than long QT syndrome
and diabetes need to be further examined.
As mentioned above, SNP rs2237892 has been reported to
be associated with T2DM in the population of Asians,
Europeans, and American Indians. It has also been
investigated in several studies in the Chinese population
[15,16], however, these studies showed conflicting results. Inthis study, we chose the SNP rs2237892, the most common
SNP of KCNQ1, to explore its association with not only
T2DM but also its complications in a Chinese Han population
from Wenzhou, Zhejiang province, for which there was no
related report yet. Based on our data, we confirmed that
rs2237892 was associated with an increased risk of T2DM in
the population. We also found that compared with genotypes
TT and CT, genotype CC was associated with a tendency of
increasing incidence of hypertension and macrovascular com-
plications in patients with T2DM.Results
Patients’ clinical characteristics
A total of 530 subjects diagnosed with T2DM and 452 non-
diabetic control subjects were recruited in this study. Com-
pared to controls, T2DM patients had significantly higher
blood pressure and higher levels of fasting blood glucose
(FBG), triglycerides, and total cholesterol, but significantly
lower level of high-density lipoprotein (HDL) (P< 0.001 for
each variable) (Table 1). These data indicated the typical clin-
ical manifestations of T2DM and metabolic syndrome.Genotyping rs2237892 variants in T2DM patients
Genotypes of the SNP rs2237892 were determined according
to the results of high-resolution melting (HRM) and DNA
sequencing (Figure 1). The genotype distribution is summa-
rized in Table 2. The genotype distribution of the variant
was in accordance with Hardy–Weinberg equilibrium among
the subjects (P> 0.05). The distribution of the genotypes
between T2DM patients and controls was significantly differ-
ent (P< 0.001). When the TT genotype was set as the refer-
ence, both the CT and CC genotypes were associated with
an increased risk of T2DM (OR, 1.97; 95% CI, 1.24–3.15
for CT; and OR, 2.49; 95% CI, 1.57–3.95 for CC, respectively,
Table 2). The allelic frequencies of the variant also differed sig-
nificantly between the two cohorts (P< 0.001). With the T
allele of rs2237892 set as the reference, the C allele was associ-
ated with an increased risk of T2DM (P< 0.001, OR, 1.45;
95% CI, 1.20–1.75). Thus, our findings are consistent with
previous studies showing that the risk allele of the rs2237892
variant in KCNQ1 might contribute to susceptibility to
T2DM [11–13].Association between genotypes and clinical characteristics
of T2DM patients
We then investigated the association between the three genotypes
and the clinical characteristics of the T2DM subjects. Using the
Table 1 Clinical characteristics of Chinese Han T2DM patients and controls
Parameter T2DM (n = 530) Control (n = 452) P value
Age (years) 60.95 ± 12.62 58.83 ± 11.40 0.019
Gender (male/female) 281/249 230/222 0.505
Body mass index (kg/m2) 24.24 ± 3.39 22.32 ± 2.20 <0.001
Blood pressure (mmHg)
Systolic blood pressure 142.81 ± 24.7# 119.11 ± 11.51 <0.001
Diastolic blood pressure 80.23 ± 11.64# 74.65 ± 8.25 <0.001
Fasting blood glucose (mM) 8.89 ± 3.98 4.96 ± 0.64 <0.001
Total cholesterol (mM) 4.50 ± 1.18 4.81 ± 0.76 <0.001
Triglyceride (mM) 1.64 ± 1.27 1.16 ± 0.54 <0.001
High-density lipoprotein (mM) 1.18 ± 0.38 1.41 ± 0.31 <0.001
Note: Values are presented as mean ± SD except the gender. P values were determined using a one-way analysis of variance except Chi-square
analysis for the gender. # Blood pressure data were missing for one T2DM patient. T2DM, type 2 diabetes mellitus.
Figure 1 Genotyping of rs2237892 variant in KCNQ1
A. Genotyping of rs2237892 was performed using HRM analysis. Relative fluorescence intensity was plotted for different genotypes at
indicated temperature. B. HRM genotyping results were validated by DNA sequencing. Genotypes were identified as CC, CT, and TT.
HRM, high-resolution melting
Table 2 Genotype distribution and allele frequency among Chinese Han T2DM patients and controls
Genotype or allele
Genotype frequency, number (%)
P value Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)Diabetes (n = 530) Control (n = 452)
Genotype
TT 39 (7.36) 66 (14.60) <0.001 1.00 1.00
CT 217 (40.94) 192 (42.48) 1.91 (1.23–2.97) 1.97 (1.24–3.15)
CC 274 (51.70) 194 (42.92) 2.39 (1.55–3.70) 2.49 (1.57–3.95)
Allele
T 295 (27.83) 324 (35.84) <0.001
C 765 (72.17) 580 (64.16) 1.45 (1.20–1.75)
Note: P values were determined using Chi-square test. OR was calculated using multivariate logistic regression analyses without and with
adjustment for gender, age, and body mass index. T2DM, type 2 diabetes mellitus; OR, odds ratio; CI, confidence interval.
366 Genomics Proteomics Bioinformatics 13 (2015) 364–370CC/(CT+ TT) model, we found that systolic blood pressure
was significantly higher in patients with genotype CC than in
the combined group with genotype CT or TT (P= 0.03), evenwith multivariate logistic regression analysis adjusted for age,
gender, and BMI (P= 0.015) (Table 3). None of the other vari-
ables differed significantly between the genotypes.
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hypertension (systolic blood pressureP140 mmHg or diastolic
blood pressure P90 mmHg). Adjusted multivariate logistic
regression analysis indicated that high systolic blood pressure,
but not high diastolic blood pressure, was significantly more
prevalent in patients with the CC genotype than in those with
the CT/TT genotypes (P= 0.037) (Table 4). These data sug-
gest that the CC genotype might contribute to a higher occur-
rence of hypertension among subjects with T2DM.
Association between genotypes and diabetic complications
in T2DM patients
To assess the association of the three genotypes and the two
alleles of the rs2237892 variants in the aggravation of diabeticTable 3 Clinical characteristics of Chinese Han T2DM patients by ge
Parameter
TT (n = 39)
Age (years) 61.62 ± 11.91
Gender (male/female) 21/18
Body mass index (kg/m2) 24.43 ± 3.63
Blood pressure (mm Hg)
Systolic blood pressure 139.38 ± 21.34
Diastolic blood pressure 80.10 ± 11.53
Fasting blood glucose (mM) 9.97 ± 6.44
Total cholesterol (mM) 4.40 ± 1.04
Triglyceride (mM) 1.61 ± 1.34
High-density lipoprotein (mM) 1.17 ± 0.33
Note: Values are presented as mean ± SD except for the gender. P values w
analysis for the gender. P value with multivariate logistic regression anal
Comparison between CC genotype vs. CT+ TT genotypes was performed
patient with CC genotype (n= 273). T2DM, type 2 diabetes mellitus.
Table 4 Association of genotypes with risk of hypertension in Chinese
Blood pressure
Genotype
TT (n = 39) CT (n
Systolic
<140 mmHg 18 (46.15) 103 (4
P140 mmHg 21 (53.85) 114 (5
Diastolic
<90 mmHg 30 (76.92) 174 (8
P90 mmHg 9 (23.08) 43 (19
Note: P values were determined using Chi-square analysis. Multivariate log
and body mass index. The comparison between CC genotype vs. CT+ TT




Macrovascular disease 15 (38.46) 105 (48.39) 147 (53.65)
Diabetic retinopathy 17 (43.59) 101 (46.54) 148 (54.01)
Diabetic nephropathy 7 (17.95) 63 (29.03) 77 (28.10)
Diabetic neuropathy 24 (61.54) 108 (49.77) 149 (54.38)
Note: P values for allele frequency (a) and genotype distribution (b) were de
was performed for CC genotype vs. TT genotype after adjusted for age, gecomplications, we divided the T2DM patients into four
groups: macrovascular disease, diabetic retinopathy, diabetic
nephropathy, and diabetic neuropathy. The frequency of both
macrovascular disease and diabetic retinopathy increased in
the order from genotypes TT to CT to CC, suggesting that
the risk allele may be associated with susceptibility to both
macrovascular disease (OR, 1.29; 95% CI, 0.99–1.69;
P= 0.06) and diabetic retinopathy (OR, 1.28; 95% CI,
0.98–1.67; P= 0.07), although the associations were not sig-
nificant (Table 5). We thus performed the multivariate logistic
regression analysis for the genotypes after adjusted by age,
gender, and BMI. Interestingly, we found that, compared to
the TT genotype, the CC genotype showed the tendency to
increase the risk of macrovascular disease in T2DM patients
(OR, 2.10; 95% CI, 1.00–4.45; P= 0.05).notype
Genotype
P value
CT (n = 217) CC (n = 274)
60.55 ± 13.27 61.17 ± 12.21 0.675
110/107 150/124 0.410
24.24 ± 3.58 24.21 ± 3.20 0.846
140.57 ± 24.33 145.06 ± 25.36 0.030
0.015#
79.13 ± 11.93 81.13 ± 11.40 0.067
8.51 ± 3.34 9.03 ± 3.98 0.357
4.41 ± 1.21 4.60 ± 1.18 0.070
1.72 ± 1.44 1.59 ± 1.10 0.527
1.18 ± 0.37 1.18 ± 0.40 0.791
ere determined using a one-way analysis of variance except Chi-square
ysis adjusted for age, gender, and body mass index is indicated by #.




= 217) CC (n = 273)
7.47) 105 (38.46) 0.037
2.53) 168 (61.54)
0.18) 209 (75.56) 0.340
.82) 64 (23.44)
istic regression analysis was performed after adjusted for age, gender,
genotypes was performed using recessive model.
n Chinese Han T2DM patients
P value
OR (95% CI)a OR (95% CI)c
Pa Pb Pc
0.06 0.16 0.05 1.29 (0.99–1.69) 2.10 (1.00–4.45)
0.07 0.18 0.21 1.28 (0.98–1.67) 1.55 (0.78–3.08)
0.46 0.36 0.17 1.12 (0.83–1.52) 1.85 (0.77–4.43)
0.96 0.32 0.40 1.01 (0.77–1.32) 0.74 (0.37–1.48)
termined using Chi-square test. Multivariate logistic regression analysis
nder, and body mass index (c). T2DM, type 2 diabetes mellitus.
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KCNQ1 mutations are associated with cardiac diseases such as
hereditary long QT syndrome and familial atrial fibrillation [7].
As a primary potassium channel subunit, KCNQ1 is expressed
in other tissues as well, including the brain, adipose tissue, and
pancreas [17–19]. In 2008, it was demonstrated that three vari-
ants of rs2283228, rs2237895, and rs2237895 within KCNQ1
were strongly associated with an increased risk of T2DM in
East Asian and European populations [11], and rs2237892
was associated with type 2 diabetes in two independent
Japanese populations, as well as Korean, Chinese, and
European ancestry [20]. For the Chinese population, it has
been confirmed in several independent studies that these
variants of KCNQ1 could confer susceptibility to T2DM, how-
ever, various studies showed conflicting results in terms of the
variants involved [15,16,21], and the association has not been
verified in the population of Wenzhou.
In the present study, we examined the contribution of the
variant rs2237892 to the risk of T2DM and its complications
in the Chinese Han population from Wenzhou of Zhejiang
province, which is in southeast China. We also found a signif-
icant association with T2DM in that the C allele conferred an
increased risk of the disease, which was consistent with previ-
ous reports [21–23].
KCNQ1 confers a risk for T2DM by impairing b-cell func-
tion [24]. The variants (rs2074196, rs2237892, rs2237895, and
rs2237897) are significantly associated with impaired FBG
[25] and reduced insulin release following an oral glucose load
[26]. Other studies have indicated that KCNQ1 is associated
with obesity [16] and triglyceride levels [27] in Chinese Han
populations. Polymorphisms in the KCNQ1 gene were report-
edly related with the therapeutic efficacy of repaglinide in
treating Chinese patients with T2DM [28]. However, in our
study, we failed to replicate the significant differences in
BMI, FBG, and lipid levels among T2DM subjects with differ-
ent genotypes, possibly as a result of the low power of our
study to detect quantitative traits, probably suggesting that
KCNQ1 is not a major factor associated with these traits. Nev-
ertheless, using multivariate logistic regression analysis with
adjustment for age, gender, and BMI, we discovered that both
systolic blood pressure and the prevalence of hypertension
were significantly higher in T2DM patients with the CC geno-
type than in those with the CT/TT genotypes. The contempo-
rary incidence of hypertension and diabetes was distinct across
different ethnic, racial, and social groups. Hypertension
occurred in nearly 70% of diabetic patients and was approxi-
mately twice as common in individuals with diabetes than in
those without diabetes [29]. It has been documented that
Kv7 channels encoded by KCNQ gene family contributed to
vasoconstriction and hypertension [30], which was in concert
with the discovery that both C3H/HeJCrl-Kcnq1vtg-2J/J mice
[31] and WTC-dfk rats [32] with a KCNQ1 mutation exhibited
significantly higher blood pressure. Taken together, these find-
ings suggest that KCNQ1 mediates the development of hyper-
tension in patients with T2DM.
Hypertension in patients with diabetes greatly increases the
risk of vascular complications in this population. Moreover,
both hypertension and diabetes predispose an individual to
chronic kidney disease [33]. Therefore, the increased risk of
hypertension observed for T2DM patients with the CC geno-type suggests a role for the risk allele C at rs2237892 in the
development of diabetic complications. In our study, the
prevalence of macrovascular disease increased in T2DM
patients from the TT to the CT and finally the CC genotypes.
Multivariate regression analysis after adjusted by age, gender,
and BMI demonstrated that the T2DM patients with the CC
genotype were twice as likely to have macrovascular complica-
tions as those with the TT genotype. Diabetic retinopathy and
diabetic nephropathy also tended to be more prevalent with a
genotype of CC than of TT.
In conclusion, the association of KCNQ1 variant rs2237892
susceptibility to T2DM was replicated in a Chinese Han pop-
ulation. Moreover, although it needs to be further confirmed in
a larger population, we discovered that the genotype CC of
rs2237892 tended to be associated with the increased risk of
hypertension and macrovascular complications in T2DM
patients, suggesting a potential biomarker predicting the devel-
opment of complications that could be identified at an early
stage of T2DM.Materials and methods
Subjects and samples
The diagnosis of T2DM was made in accordance with the World
Health Organization (WHO) 1999 criteria [34] and the China
Guideline for Type 2 Diabetes 2010 (Chinese Diabetes Society)
[35]. Known subtypes of diabetes such as type 1 diabetes and
secondary diabetes were excluded. All patients were admitted in
hospital without previous treatment. Control subjects were indi-
viduals with a FBG level <6.1 mM and normal glucose tolerance,
without family history of diabetes mellitus. Diabetic complications
were diagnosed by diabetologists according to the clinical manifes-
tations and a related auxiliary examination.
All participants were of Chinese Han origin, non-
sanguineous, and recruited between May 2009 and October
2010 from the First Affiliated Hospital of Wenzhou Medical
University, Wenzhou, China. Written informed consent was
obtained from the subjects prior to participation. Clinical
evaluations were approved by the Ethics Committee of the
Wenzhou Medical University Institutional Review Board.
Height, body weight, and blood pressure were measured for
all subjects. Blood samples were drawn for biochemical mea-
surements: FBG, total cholesterol, triglyceride, HDL. Geno-
mic DNA was extracted from peripheral whole blood using
Takara blood DNA isolation kits (Takara, Dalian, China)
and quantified using a NanoDrop ND-2000 spectrophotome-
ter (Thermo Fisher Scientific, Waltham, MA).
Genotyping using HRM
Genotyping was performed using a LightCycler 480 System II
(Roche Diagnostics, Penzberg, Germany). A 116-bp fragment
spanning the rs2237892 loci was amplified for subsequent
HRM analysis with primers 50-AGAGGAAGAGCAAGGG
TAGG-30 (forward) and 50-GGTGTAAGGCATCTGGTG
G-30 (reverse), designed against GenBank sequence with acces-
sion No. NC_000011.10. PCR amplification was performed as
instructed by the manufacturer. The amplification products
were heated to 95 C for 1 min and then cooled to 40 C for
Zhang W et al / KCNQ1 Variant in Chinese with Type 2 Diabetes 3691 min. HRM was subsequently performed over a range of 65–
95 C, increasing at 1 C/s with 25 acquisitions per 1 C step.
HRM curves were generated using the LightCycler 480 gene
scanning software module with manual settings for sensitivity
to 0.30, a temperature shift to threshold 4, a pre-melt normal-
ization range of 70–78 C, and a post-melt normalization
range of 85–90 C. The melting curves were normalized for
direct comparison among samples [36].
Genotyping using DNA sequencing
To confirm the HRM results, samples were randomly selected
for DNA sequencing. A 500-bp fragment spanning the
rs2237892 locus was amplified for DNA sequencing using the
primers designed against GenBank sequence NC_000011.10,
50-GTGCATCCTAAGGTGGTTC-30 (forward) and 50-CCT
AATCCTGTAGGGCAGA-30 (reverse) following standard
protocol for PCR amplification. The PCR products were puri-
fied using a QIAquick PCR purification kit (Qiagen, Valencia,
CA) and subsequently analyzed by direct sequencing with an
ABI 3730XL automated DNA sequencer in BGI (Beijing,
China).
Statistical analysis
Quantitative clinical data (age, BMI, blood pressure, FBG,
total cholesterol, triglyceride, and HDL) were presented as
mean ± standard deviations and compared using a one-way
analysis of variance. To correct for non-normally distributed
data, concentrations of FBG, total cholesterol, triglyceride,
and HDL were log-transformed. Gender, which is presented
as binary data (male/female), was compared using the
Chi-square test.
Genotype distribution and allelic frequencies are presented
as number (%) and were analyzed using a Chi-square test or
multivariate logistic regression analysis. Multivariate logistic-
regression analysis was performed to adjust for risk factors,
with T2DM as a dependent variable and independent variables
including age, sex, and BMI. Results are presented as OR and
95% CI. All values of P< 0.05 were considered significant.
The statistical analyses were performed with SPSS version
17.0 software (SPSS, Chicago, IL, USA).
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